Mr. Gelfand, Montréal Exchange Vice-President, is elected to the Board
MONTREAL, June 18, 2012 /CNW Telbec/ - Brian Z. Gelfand was elected as a
member of the IRCM's Board of Directors at the institute's annual
general meeting held last week.
"We are very proud to welcome Mr. Gelfand on our Board of Directors,"
said Louise Lambert-Lagacé, Chairwoman of the Board. "The IRCM will
unquestionably benefit from his influence in numerous international
networks and community organizations."
Brian Z. Gelfand is Vice-President of Institutional Relations and Market
Operations at the Montréal Exchange. Mr. Gelfand previously worked as a
consultant, an attorney, and a Special Advisor to the Secretary General
at the International Organization of Securities Commissions. He is a
member of the Bars of Quebec, New York and Massachusetts.
"I am pleased to be part of the IRCM's Board of Directors," added Mr.
Gelfand. "It became clear when I attended the annual assembly that I am
joining a very important institution for the city of Montréal, and one
where high-performing researchers are making discoveries that will
impact the future health of all Canadians."
About Brian Z. Gelfand
Brian Z. Gelfand is a senior executive in the derivatives exchange
sector with leadership experience in all aspects of options and futures
markets. He is currently Vice-President of Institutional Relations and
Market Operations at the Montréal Exchange. Mr. Gelfand is a member of
the Bars of Quebec, New York and Massachusetts. He holds a Bachelors of
Arts in Economics, a Bachelor of Civil Law and a Bachelor of Common Law
from McGill University, as well as an M.A. in international relations
from the John Hopkins University. He is an active member of several
professional and community organizations, including the Toronto
Centre's Securities Program Advisory Board, AIMA Canada's Education and
Research Committee, and the Roaster's Foundation.
About the IRCM
Founded in 1967, the IRCM (www.ircm.qc.ca) is currently comprised of 36 research units in various fields, namely
immunity and viral infections, cardiovascular and metabolic diseases,
cancer, neurobiology and development, systems biology and medicinal
chemistry. It also houses three specialized research clinics, seven
core facilities and three research platforms with state-of-the-art
equipment. The IRCM employs 425 people and is an independent
institution affiliated with the Université de Montréal. The IRCM clinic
is associated to the Centre hospitalier de l'Université de Montréal
(CHUM). The IRCM also maintains a long-standing association with McGill
SOURCE Institut de recherches cliniques de Montréal
For further information:
Communications Director, IRCM
514-987-5535 | email@example.com